Characteristics of Peripartum Cardiomyopathy (PPCM) pregnancy and preeclampsia in Dr Soetomo Hospital, Surabaya, Indonesia, 2014-2016
Downloads
Objectives: to present data on the characteristics of pregnancy with PPCM and PE. Management of patients with PPCM is almost the same as for patients with acute or chronic heart failure, which uses drug therapy. PPCM and preeclampsia (PE) are two related diseases, although not directly. Both have similar pathophysiological mechanisms.
Case Report: We present 25 pregnancy cases with PPCM at Dr. Soetomo Hospital within 3 years. Data were collected from January 2014 to December 2016, consisting of 5 PPCM cases and the other 20 cases were PPCM with PE cases.
Conclusion: Pregnancy with PPCM-PE has higher morbidity than PPCM only. The diagnosis of PPCM should be established immediately if heart failure symptoms are found in the third trimester and the patient has risk factors, such as age >30 years, multigravida, obesity, and multiple pregnancy.Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;1;136(5).
Aziz MF. Gynecological cancer in Indonesia. Journal of Gynecologic Oncology. 2009;20(1):8-10.
Ries LA, Young Jr JL, Keel GE, et al. Cancer survival among adults: US SEER program, 1988–2001. Patient and tumor characteristics SEER Survival Monograph Publication. 2007:07-6215.
Lang SM, Mills AM, Cantrell LA. Malignant Brenner tumor of the ovary: Review and case report. Gynecologic Oncology Reports. 2017.
Hemalatha AL, Konanahalli P. Bilateral malignant Brenner tumor of ovary. J Obstet Gynecol India. 2005;55(1):81-2.
Bean LM, Anderson KM, Taylor K, et al. Malig-nant Brenner tumor of the ovary: A population-based study. Gynecologic Oncology. 2016;141: 201
Dierickx I, Valentin L, Van Holsbeke C, et al. Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary. Ultrasound in Obstetrics & Gynecology. 2012;40 (6):706-13.
Berek and Novak's. Gynecology. 15th edn. Lippin-cott Williams and Wilkins, 2012, p. 1560.
Verma A, Chander B, Verma S, Soni A. Malignant brenner tumor of ovary. The Journal of Obstetrics and Gynecology of India. 2014;1:1-2.
Gezginç K, Karatayli R, Yazici F, et al. Malignant Brenner tumor of the ovary: Analysis of 13 cases. International Journal of Clinical Oncology. 2012; 17(4):324-9.
Nasioudis D, Sisti G, Holcomb K, et al. Malignant Brenner tumors of the ovary; a population-based analysis. Gynecologic Oncology. 2016;142(1):44-9.
Organisation mondiale de la santé, Centre interna-tional de recherche sur le cancer. WHO classifica-tion of tumours of female reproductive organs. IARC press; 2014.
Han JH, Kim DY, Lee SW, et al. Intensive systemic chemotherapy is effective against recurrent malig-nant Brenner tumor of the ovary: An analysis of 10 cases within a single center. Taiwanese Journal of Obstetrics and Gynecology. 2015;54(2):178-82.
Hull MG, Campbell GR. The malignant Brenner tumor. Obstetrics & Gynecology. 1973;42(4):527-hyhen.
Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and mole-cular genetic analysis of Brenner tumors and transi-tional cell carcinomas. The American Journal of Surgical Pathology. 2009;33(4):556-67.
Roma AA, Masand RP. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor. Annals of diagnostic pathology. 2015;19(1):29-32.
Seidman JD, Khedmati F. Exploring the histogen-esis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors. Archives of Pathology & Laboratory Medicine. 2008;132(11):1753-60.
Austin RM, Norris HJ. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. International Journal of Gynecological pathology. 1987;6(1):29-39.
Tlahuel JL, Heredia RD, Morales JR, Salazar JG. Transitional cell carcinoma of the ovary: A case report and review of the literature. Journal of Cancerology. 2014;1:32-5
Ali RH, Seidman JD, Luk M, et al. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor. International Journal of Gyneco-logical Pathology. 2012;31(6):499-506.
Ingin RJ, Andola SK, Zubair AA. Transitional cell carcinoma of the ovary: case series and review of literature. Journal of Clinical and Diagnostic Research: JCDR. 2014;8(8):FD07.
Gill SE, McGree ME, Weaver AL, et al. Optimi-zing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus prima-ry debulking surgery for epithelial ovarian cancers likely to have suboptimal resection. Gynecologic Oncology. 2017;144(2):266-73.
Ozols RF, Bundy BN, Greer BE, et al. Phase III trial of carboplatin and paclitaxel comparedwith cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. Journal of Clinical Onco-logy. 2003;21(17):3194-200.
Chundury A, Apicelli A, DeWees T, et al. Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy. Gynecologic Oncology. 2016;141(1):134-9.
Pepin K, del Carmen M, Brown A, Dizon DS. CA-125 and epithelial ovarian cancer: Role in screen-ing, diagnosis, and surveillance. American Journal of Hematology/Oncology. 20141;10(6).
Dail DH, Cagle PT, Marchevsky AM, et al. Meta-stases to the lung. In: Travis WD, Brambilia E, Muller-Hermelink HK, Harris C, editors. Tumor of the lung. Lyon-France: IARC;2004 p. 121-4.
Ryback BJ, Ober WB, Bernacki Jr EG. Malignant Brenner tumor of the ovary. Report of three cases. Diagnostic Gynecology and Obstetrics. 1981;3(1): 61-74.
Yamamoto R, Fujita M, Kuwabara M, et al. Malig-nant Brenner tumors of the ovary and tumor markers. Japanese Journal of Clinical Oncology. 1999;29(6):308-13.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
